Canine Stem Cell Therapy Market : Table of Content


  • Published On : Apr-2018 |
  • Pages : 230 Pages |
  • Format : Canine Stem Cell Therapy Market Canine Stem Cell Therapy Market Canine Stem Cell Therapy Market Canine Stem Cell Therapy Market

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. PMR Analysis and Recommendations
     1.4. Wheel of Fortune

2. Market Introduction
     2.1. Market Definition
     2.2. Market Taxonomy

3. Canine Stem Cell Therapy Market Opportunity Analysis
     3.1. Macro-Economic Factors
     3.2. Opportunity Analysis

4. Market Background
     4.1. Evolution of Stem Cell Therapy In Veterinary
     4.2. Market Dynamics
            4.2.1. Drivers
            4.2.2. Restraints
            4.2.3. Opportunity Analysis
     4.3. Regulatory Scenario

5. Key Inclusions
     5.1. Key Manufacturer List
     5.2. Pricing Analysis

6. North America Canine Stem Cell Therapy Market Analysis 2012–2016 and Forecast 2017–2025
     6.1. Introduction
     6.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
            6.2.1. U.S.
            6.2.2. Canada
     6.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
     6.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            6.4.1. Autologous Stem Cell
            6.4.2. Allogeneic Stem Cell
     6.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2025
     6.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
            6.6.1. Arthritis
            6.6.2. Lameness
            6.6.3. Dysplasia
            6.6.4. Tendonitis
            6.6.5. Others
     6.7. Market Size (US$ Mn) Forecast By Application, 2017–2025
     6.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
            6.8.1. Veterinary Hospitals
            6.8.2. Veterinary Clinics
            6.8.3. Veterinary Research Institutes
     6.9. Market Size (US$ Mn) Forecast By End User, 2017–2025
     6.10. Drivers and Restraints: Impact Analysis
     6.11. Market Attractiveness Analysis
            6.11.1. By Country
            6.11.2. By Product Type
            6.11.3. By Application
            6.11.4. By End User
     6.12. Key Takeaways

7. Latin America Canine Stem Cell Therapy Market Analysis 2012–2016 and Forecast 2017–2025
     7.1. Introduction
     7.2. Historical Market Size (US$ Mn) Trends Analysis By Country, 2012–2016
            7.2.1. Argentina
            7.2.2. Brazil
            7.2.3. Mexico
            7.2.4. Rest of Latin America
     7.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
     7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            7.4.1. Autologous Stem Cell
            7.4.2. Allogeneic Stem Cell
     7.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2025
     7.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
            7.6.1. Arthritis
            7.6.2. Lameness
            7.6.3. Dysplasia
            7.6.4. Tendonitis
            7.6.5. Others
     7.7. Market Size (US$ Mn) Forecast By Application, 2017–2025
     7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
            7.8.1. Veterinary Hospitals
            7.8.2. Veterinary Clinics
            7.8.3. Veterinary Research Institutes
     7.9. Market Size (US$ Mn) Forecast By End User, 2017–2025
     7.10. Drivers and Restraints: Impact Analysis
     7.11. Market Attractiveness Analysis
            7.11.1. By Country
            7.11.2. By Product Type
            7.11.3. By Application
            7.11.4. By End User
     7.12. Key Takeaways

8. Europe Canine Stem Cell Therapy Market Analysis 2012–2016 and Forecast 2017–2025
     8.1. Introduction
     8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            8.2.1. Germany
            8.2.2. U.K.
            8.2.3. France
            8.2.4. Italy
            8.2.5. Spain
            8.2.6. Russia
            8.2.7. Rest of Europe
     8.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
     8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            8.4.1. Autologous Stem Cell
            8.4.2. Allogeneic Stem Cell
     8.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2025
     8.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
            8.6.1. Arthritis
            8.6.2. Lameness
            8.6.3. Dysplasia
            8.6.4. Tendonitis
            8.6.5. Others
     8.7. Market Size (US$ Mn) Forecast By Application, 2017–2025
     8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
            8.8.1. Veterinary Hospitals
            8.8.2. Veterinary Clinics
            8.8.3. Veterinary Research Institutes
     8.9. Market Size (US$ Mn) Forecast By End User, 2017–2025
     8.10. Drivers and Restraints: Impact Analysis
     8.11. Market Attractiveness Analysis
            8.11.1. By Country
            8.11.2. By Product Type
            8.11.3. By Application
            8.11.4. By End User
     8.12. Key Takeaways

9. APEJ Canine Stem Cell Therapy Market Analysis 2012–2016 and Forecast 2017–2025
     9.1. Introduction
     9.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            9.2.1. Japan
            9.2.2. India
            9.2.3. Australia and New Zealand
            9.2.4. Rest of APEJ
     9.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
     9.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            9.4.1. Autologous Stem Cell
            9.4.2. Allogeneic Stem Cell
     9.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2025
     9.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
            9.6.1. Arthritis
            9.6.2. Lameness
            9.6.3. Dysplasia
            9.6.4. Tendonitis
            9.6.5. Others
     9.7. Market Size (US$ Mn) Forecast By Application, 2017–2025
     9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
            9.8.1. Veterinary Hospitals
            9.8.2. Veterinary Clinics
            9.8.3. Veterinary Research Institutes
     9.9. Market Size (US$ Mn) Forecast By End User, 2017–2025
     9.10. Drivers and Restraints: Impact Analysis
     9.11. Market Attractiveness Analysis
            9.11.1. By Country
            9.11.2. By Product Type
            9.11.3. By Application
            9.11.4. By End User
     9.12. Key Takeaways

10. Japan Canine Stem Cell Therapy Market Analysis 2012–2016 and Forecast 2017–2025
     10.1.Introduction
     10.2.Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            10.2.1. Autologous Stem Cell
            10.2.2. Allogeneic Stem Cell
     10.3.Market Size (US$ Mn) Forecast By Product Type, 2017–2025
     10.4.Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
            10.4.1. Arthritis
            10.4.2. Lameness
            10.4.3. Dysplasia
            10.4.4. Tendonitis
            10.4.5. Others
     10.5.Market Size (US$ Mn) Forecast By Application, 2017–2025
     10.6.Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
            10.6.1. Veterinary Hospitals
            10.6.2. Veterinary Clinics
            10.6.3. Veterinary Research Institutes
     10.7. Market Size (US$ Mn) Forecast By End User, 2017–2025
     10.8. Drivers and Restraints: Impact Analysis
     10.9. Market Attractiveness Analysis
            10.9.1. By Product Type
            10.9.2. By Application
            10.9.3. By End User
     10.10. Key Takeaways

11. Middle East & Africa Canine Stem Cell Therapy Market Analysis 2012–2016 and Forecast 2017–2025
     11.1.Introduction
     11.2.Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            11.2.1. GCC Countries
            11.2.2. South Africa
            11.2.3. Rest of MEA
     11.3.Market Size (US$ Mn) Forecast By Country, 2017–2025
     11.4.Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            11.4.1. Autologous Stem Cell
            11.4.2. Allogeneic Stem Cell
     11.5.Market Size (US$ Mn) Forecast By Product Type, 2017–2025
     11.6.Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
            11.6.1. Arthritis
            11.6.2. Lameness
            11.6.3. Dysplasia
            11.6.4. Tendonitis
            11.6.5. Others
     11.7.Market Size (US$ Mn) Forecast By Application, 2017–2025
     11.8.Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
            11.8.1. Veterinary Hospitals
            11.8.2. Veterinary Clinics
            11.8.3. Veterinary Research Institutes
     11.9. Market Size (US$ Mn) Forecast By End User, 2017–2025
     11.10. Drivers and Restraints: Impact Analysis
     11.11. Market Attractiveness Analysis
            11.11.1. By Country
            11.11.2. By Product Type
            11.11.3. By Application
            11.11.4. By End User
     11.12. Key Takeaways

12. Forecast Factors: Relevance and Impact

13. Forecast Assumptions

14. Company Profiles
     14.1.Company Deep Dive
            14.1.1. VETSTEM BIOPHARMA
                     14.1.1.1. Overview
                     14.1.1.2. Product and Application Portfolio
                     14.1.1.3. Production Footprint
                     14.1.1.4. Sales Footprint
                     14.1.1.5. Channel Footprint
                     14.1.1.6. Strategy
                                14.1.1.6.1.1. Marketing Strategy
                                14.1.1.6.1.2. Product Strategy
                                14.1.1.6.1.3. Channel Strategy
            14.1.2. Aratana Therapeutics
                     14.1.2.1. Overview
                     14.1.2.2. Product and Application Portfolio
                     14.1.2.3. Production Footprint
                     14.1.2.4. Sales Footprint
                     14.1.2.5. Channel Footprint
                     14.1.2.6. Strategy
                                14.1.2.6.1.1. Marketing Strategy
                                14.1.2.6.1.2. Product Strategy
                                14.1.2.6.1.3. Channel Strategy
            14.1.3. Medivet Biologics LLC
                     14.1.3.1. Overview
                     14.1.3.2. Product and Application Portfolio
                     14.1.3.3. Production Footprint
                     14.1.3.4. Sales Footprint
                     14.1.3.5. Channel Footprint
                     14.1.3.6. Strategy
                                14.1.3.6.1.1. Marketing Strategy
                                14.1.3.6.1.2. Product Strategy
                                14.1.3.6.1.3. Channel Strategy
            14.1.4. Okyanos
                     14.1.4.1. Overview
                     14.1.4.2. Product and Application Portfolio
                     14.1.4.3. Production Footprint
                     14.1.4.4. Sales Footprint
                     14.1.4.5. Channel Footprint
                     14.1.4.6. Strategy
                                14.1.4.6.1.1. Marketing Strategy
                                14.1.4.6.1.2. Product Strategy
                                14.1.4.6.1.3. Channel Strategy
            14.1.5. Vetbiologics
                     14.1.5.1. Overview
                     14.1.5.2. Product and Application Portfolio
                     14.1.5.3. Production Footprint
                     14.1.5.4. Sales Footprint
                     14.1.5.5. Channel Footprint
                     14.1.5.6. Strategy
                                14.1.5.6.1.1. Marketing Strategy
                                14.1.5.6.1.2. Product Strategy
                                14.1.5.6.1.3. Channel Strategy
            14.1.6. VetMatrix
                     14.1.6.1. Overview
                     14.1.6.2. Product and Application Portfolio
                     14.1.6.3. Production Footprint
                     14.1.6.4. Sales Footprint
                     14.1.6.5. Channel Footprint
                     14.1.6.6. Strategy
                                14.1.6.6.1.1. Marketing Strategy
                                14.1.6.6.1.2. Product Strategy
                                14.1.6.6.1.3. Channel Strategy
            14.1.7. Magellan Stem Cells
                     14.1.7.1. Overview
                     14.1.7.2. Product and Application Portfolio
                     14.1.7.3. Production Footprint
                     14.1.7.4. Sales Footprint
                     14.1.7.5. Channel Footprint
                     14.1.7.6. Strategy
                                14.1.7.6.1.1. Marketing Strategy
                                14.1.7.6.1.2. Product Strategy
                                14.1.7.6.1.3. Channel Strategy
            14.1.8. ANIMAL CELL THERAPIES, INC
                     14.1.8.1. Overview
                     14.1.8.2. Product and Application Portfolio
                     14.1.8.3. Production Footprint
                     14.1.8.4. Sales Footprint
                     14.1.8.5. Channel Footprint
                     14.1.8.6. Strategy
                                14.1.8.6.1.1. Marketing Strategy
                                14.1.8.6.1.2. Product Strategy
                                14.1.8.6.1.3. Channel Strategy
            14.1.9. stemcellvet.co.uk
                     14.1.9.1. Overview
                     14.1.9.2. Product and Application Portfolio
                     14.1.9.3. Production Footprint
                     14.1.9.4. Sales Footprint
                     14.1.9.5. Channel Footprint
                     14.1.9.6. Strategy
                                14.1.9.6.1.1. Marketing Strategy
                                14.1.9.6.1.2. Product Strategy
                                14.1.9.6.1.3. Channel Strategy
            14.1.10. Cell Therapy Sciences
                     14.1.10.1. Overview
                     14.1.10.2. Product and Application Portfolio
                     14.1.10.3. Production Footprint
                     14.1.10.4. Sales Footprint
                     14.1.10.5. Channel Footprint
                     14.1.10.6. Strategy
                                14.1.10.6.1.1. Marketing Strategy
                                14.1.10.6.1.2. Product Strategy
                                14.1.10.6.1.3. Channel Strategy
            14.1.11. Regeneus Ltd.
                     14.1.11.1. Overview
                     14.1.11.2. Product and Application Portfolio
                     14.1.11.3. Production Footprint
                     14.1.11.4. Sales Footprint
                     14.1.11.5. Channel Footprint
                     14.1.11.6. Strategy
                                14.1.11.6.1.1. Marketing Strategy
                                14.1.11.6.1.2. Product Strategy
                                14.1.11.6.1.3. Channel Strategy

15. Global Canine Stem Cell Therapy Market Analysis 2012–2016 and Forecast 2017–2025, By Region
     15.1. Introduction/Key Findings
     15.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
     15.3. Market Size (US$ Mn) Forecast By Region, 2017–2025
            15.3.1. North America
            15.3.2. Latin America
            15.3.3. Europe
            15.3.4. APEJ
            15.3.5. Middle East & Africa
            15.3.6. Japan
     15.4.Market Attractiveness Analysis By Region

16. Global Canine Stem Cell Therapy Analysis 2012–2016 and Forecast 2017–2025, By Product Type
     16.1. Introduction/Key Findings
     16.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2012–2016
            16.2.1. Autologous Stem Cell
            16.2.2. Allogeneic Stem Cell
     16.3.Market Size (US$ Mn) Forecast By Product Type, 2017–2025
     16.4.Market Attractiveness Analysis By Product Type

17. Global Canine Stem Cell Therapy Market Analysis 2012–2016 and Forecast 2017–2025, By Application
     17.1. Introduction/Key Findings
     17.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2016
            17.2.1. Arthritis
            17.2.2. Lameness
            17.2.3. Dysplasia
            17.2.4. Tendonitis
            17.2.5. Others
     17.3.Market Size (US$ Mn) Forecast By Application, 2017–2025
     17.4.Market Attractiveness Analysis By Application

18. Global Canine Stem Cell Therapy Market Analysis 2012–2016 and Forecast 2017–2025, By End User
     18.1. Introduction/Key Findings
     18.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
            18.2.1. Veterinary Hospitals
            18.2.2. Veterinary Clinics
            18.2.3. Veterinary Research Institutes
     18.3.Market Size (US$ Mn) Forecast By End User, 2017–2025
     18.4.Market Attractiveness Analysis By End User

19. Global Canine Stem Cell Therapy Market Analysis 2012–2016 and Forecast 2017–2025
     19.1.Market Value Share Analysis By All Segment
     19.2.Y-o-Y Growth Analysis By All Segment
     19.3.Absolute $ Opportunity


List of Table

Table 01: Global Key Company and Product Mapping
Table 02: Canine Stem Cell Therapy Average Cost (US$/Therapy), By Product Type
Table 03: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Country
Table 04: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Product
Table 05: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Application
Table 06: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By End User
Table 07: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Country
Table 08: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Product
Table 09: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Application
Table 10: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By End User
Table 11: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Country
Table 12: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Product
Table 13: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Application
Table 14: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By End User
Table 15: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Country
Table 16: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Product
Table 17: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Application
Table 18: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By End User
Table 19: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Product
Table 20: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Application
Table 21: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By End User
Table 22: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Country
Table 23: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Product
Table 24: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Application
Table 25: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By End User
Table 26: Global Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Region
Table 27: Global Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Product Type
Table 28: Global Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By Application
Table 29: Global Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014–2017 and Forecast 2018–2026, By End Use


List of Figures

Figure 01: Canine Stem Cell Therapy Market Revenue Share by Product Type 2018E & 2026F
Figure 02: Canine Stem Cell Therapy Market Revenue Share by End User, 2018E & 2026F
Figure 03: Global Market Value Share 2018E, By Application Type
Figure 04: Global Canine Stem Cell Market Revenue Opportunity Analysis, By Region 2018-2026
Figure 05: U.S. Estimated Breakdown of Pet Industry Expenditure (US$ Bn), By Service 2017
Figure 06: Total U.S. Pet Industry Expenditures (US$ Bn), 2017
Figure 07: U.S. Consumer Spending (US$ Bn) on Veterinary Care
Figure 08: Global Canine Stem Cell Therapy Average Price, 2017 - 2020
Figure 09: North America Canine Stem Cell Therapy Market Value Share (2017A)
Figure 10: North America Canine Stem Cell Therapy Market Value Share (2017A), By Country
Figure 11: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 12: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 13: U.S. Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 14: U.S. Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 15: Canada Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 16: Canada Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 17: North America Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 18: North America Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 19: North America Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 20: North America Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 21: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014–2017
Figure 22: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018–2026
Figure 23: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014–2017
Figure 24: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018–2026
Figure 25: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014–2017
Figure 26: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018–2026
Figure 27: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014–2017
Figure 28: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018–2026
Figure 29: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Others, 2014–2017
Figure 30: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Others, 2018–2026
Figure 31: North America Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
Figure 32: North America Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
Figure 33: North America Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
Figure 34: North America Canine Stem Cell Therapy Market Attractiveness Analysis, By Country
Figure 35: Latin America Canine Stem Cell Therapy Market Value Share (2017A)
Figure 36: Latin America Canine Stem Cell Therapy Market Value Share (2017A), By Country
Figure 37: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 38: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 39: Brazil Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 40: Brazil Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 41: Mexico Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 42: Mexico Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 43: Rest of Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 44: Rest of Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 45: Latin America Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 46: Latin America Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 47: Latin America Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 48: Latin America Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 49: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014–2017
Figure 50: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018–2026
Figure 51: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014–2017
Figure 52: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018–2026
Figure 53: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014–2017
Figure 54: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018–2026
Figure 55: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014–2017
Figure 56: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018–2026
Figure 57: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Others, 2014–2017
Figure 58: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Others, 2018–2026
Figure 59: Latin America Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
Figure 60: Latin America Canine Stem Cell Therapy  Market Attractiveness Analysis, By Application
Figure 61: Latin America Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
Figure 62: Latin America Canine Stem Cell Therapy Market Attractiveness Analysis, By Country
Figure 63: Europe Canine Stem Cell Therapy Market Value Share (2017A)
Figure 64: Europe Canine Stem Cell Therapy Market Value Share (2017A), By Country
Figure 65: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 66: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 67: Germany Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 68: Germany Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 69: U.K. Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 70: U.K. Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 71: France Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 72: France Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 73: Italy Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 74: Italy Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 75: Spain Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 76: Spain Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 77: Russia Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 78: Russia Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 79: Rest of Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 80: Rest of Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 81: Europe Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 82: Europe Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 83: Europe Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 84: Europe Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 85: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014–2017
Figure 86: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018–2026
Figure 87: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014–2017
Figure 88: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018–2026
Figure 89: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014–2017
Figure 90: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018–2026
Figure 91: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014–2017
Figure 92: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018–2026
Figure 93: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Others, 2014–2017
Figure 94: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Others, 2018–2026
Figure 95: Europe Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
Figure 96: Europe Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
Figure 97: Europe Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
Figure 98: Europe Canine Stem Cell Therapy Market Attractiveness Analysis, By Country
Figure 99: APEJ Canine Stem Cell Therapy Market Value Share (2017A)
Figure 100: APEJ Canine Stem Cell Therapy Market Value Share (2017A), By Country
Figure 101: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 102: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 103: India Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 104: India Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 105: Australia & New Zealand Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 106: Australia & New Zealand Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 107: Rest of APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 108: Rest of APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 109: APEJ Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 110: APEJ Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 111: APEJ Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 112: APEJ Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 113: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014–2017
Figure 114: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018–2026
Figure 115: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014–2017
Figure 116: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018–2026
Figure 117: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014–2017
Figure 118: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018–2026
Figure 119: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014–2017
Figure 120: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018–2026
Figure 121: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Others, 2014–2017
Figure 122: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Others, 2018–2026
Figure 123: APEJ Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
Figure 124: APEJ Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
Figure 125: APEJ Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
Figure 126: APEJ Canine Stem Cell Therapy Market Attractiveness Analysis, By Country
Figure 127: Japan Canine Stem Cell Therapy Market Value Share (2017A)
Figure 128: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 129: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 130: Japan Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 131: Japan Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 132: Japan Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 133: Japan Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 134: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014–2017
Figure 135: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018–2026
Figure 136: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014–2017
Figure 137: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018–2026
Figure 138: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014–2017
Figure 139: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018–2026
Figure 140: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014–2017
Figure 141: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018–2026
Figure 142: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014–2017
Figure 143: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018–2026
Figure 144: Asia Pacific Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type 
Figure 145: Japan Canine Stem Cell Therapy Market Attractiveness Analysis, By Application 
Figure 146: Japan Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
Figure 147: Middle East & Africa Canine Stem Cell Therapy Market Value Share (2017A)
Figure 148: Middle East & Africa Canine Stem Cell Therapy Market Value Share (2017A), By Country
Figure 149: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 150: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 151: GCC Countries Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 152: GCC Countries Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 153: South Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 154: South Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 155: Rest of Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 156: Rest of Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 157: Middle East & Africa Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 158: Middle East & Africa Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 159: Middle East & Africa Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014–2017
Figure 160: Middle East & Africa Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 161: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014–2017
Figure 162: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018–2026
Figure 163: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014–2017
Figure 164: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018–2026
Figure 165: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014–2017
Figure 166: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018–2026
Figure 167: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014–2017
Figure 168: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018–2026
Figure 169: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Others, 2014–2017
Figure 170: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Others, 2018–2026
Figure 171: Middle East & Africa Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
Figure 172: Middle East & Africa Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
Figure 173: Middle East & Africa Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
Figure 174: Middle East & Africa Canine Stem Cell Therapy Market Attractiveness Analysis, By Country
Figure 175: Global Canine Stem Cell Therapy Market Share Analysis (%) By Region, 2018 & 2026
Figure 176: Global Canine Stem Cell Therapy Market Y-o-Y Growth (%) By Region, 2018–2026
Figure 177: Global Canine Stem Cell Therapy Market Attractiveness Analysis By Region, 2018–2026
Figure 178: Global Canine Stem Cell Therapy Market Share Analysis (%) By Product Type, 2018 & 2026
Figure 179: Global Canine Stem Cell Therapy Market Y-o-Y Growth (%) By Product Type, 2018–2026
Figure 180: Global Canine Stem Cell Therapy Market Attractiveness Analysis By Product Type, 2018–2026
Figure 181: Global Canine Stem Cell Therapy Market Share Analysis (%) By Application, 2018 & 2026
Figure 182: Global Canine Stem Cell Therapy Market Y-o-Y Growth (%) By Application, 2018–2026
Figure 183: Global Canine Stem Cell Therapy Market Attractiveness Analysis By Application, 2018–2026
Figure 184: Global Canine Stem Cell Therapy Market Share Analysis (%) By End User, 2018 & 2026
Figure 185: Global Canine Stem Cell Therapy Market Y-o-Y Growth (%) By End User, 2018–2026
Figure 186: Global Canine Stem Cell Therapy Market Attractiveness Analysis By End User, 2018–2026
Figure 187: Global Canine Stem Cell Therapy Market Value Analysis and Forecast, 2017–2026 (US$ Mn)
Figure 188: Global Canine Stem Cell Therapy Market Value (US$ Mn), 2014–2017
Figure 189: Global Canine Stem Cell Therapy Market Absolute $ Opportunity (US$ Mn), 2017–2026

Canine Stem Cell Therapy Market - Table of Content

Back To Top